Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1631–1637. doi: 10.1158/1055-9965.EPI-08-0830

Table 3.

Association of TP53 haplotypes with risk of HPV Persistence/CIN3+, adjusted for age.

Haplotype CIN3+/ Persistent HPV Cases (Frequency) Population Controls (Frequency) OR* 95% CI*
graphic file with name nihms116314t1.jpg
A C C T C G A T G G G 0.472 0.507 1.0
A T C T C G A T G G G 0.013 0.012 1.1 0.48 2.5
A C T T C G A T G G G 0.139 0.152 1.0 0.77 1.3
A C C T C G A T C G G 0.016 0.017 1.0 0.50 2.2
A C C T C A G T C C G 0.038 0.026 1.7 0.97 2.9
A T C T C A G T C C G 0.057 0.055 1.1 0.78 1.6
A C C G T G A T C C G 0.092 0.060 1.6 1.1 2.3
A C T G T G A T C C G 0.013 0.015 0.90 0.34 2.4
G C T G T G A T C C G 0.042 0.035 1.3 0.86 2.1
A C C T C G A C C C A 0.012 0.012 0.98 0.46 2.1
A C T T C G A C C C A 0.022 0.021 1.1 0.60 1.9
Rare Haplotypes 0.084 0.088 1.0 0.73 1.5
*

OR, odds ratio. CI, confidence interval. Adjusted for age.